Citius Oncology (CTOR) Liabilities and Shareholders Equity (2021 - 2026)
Citius Oncology (CTOR) posted Liabilities and Shareholders Equity of $112.09 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 22.2% from $91.71 million a year earlier and up 11.3% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Oncology's Liabilities and Shareholders Equity came in at $100.94 million, up 19.6% from FY2024.
- Annual Liabilities and Shareholders Equity shows a four-year compound annual growth rate of 431.6% (FY2021 to FY2025).
- In prior fiscal years, Citius Oncology's Liabilities and Shareholders Equity was $84.37 million in FY2024, $72.62 million in FY2023 (+6.5%), $68.19 million in FY2022 and $126,422 in FY2021.
- The fiscal Q3 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2022.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last four quarters, with growth averaging 18.4% over the last four quarters.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $100.7 million (Q2 2026), $109.97 million (Q1 2026) and $100.94 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Citius Oncology | 72.00 Mn | 41.58 Mn | 1.00 Mn | 112.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.09 Mn |
| Mar 31, 2026 | 100.70 Mn |
| Dec 31, 2025 | 109.97 Mn |
| Sep 30, 2025 | 100.94 Mn |
| Jun 30, 2025 | 91.71 Mn |
| Mar 31, 2025 | 91.44 Mn |
| Dec 31, 2024 | 90.48 Mn |
| Sep 30, 2024 | 84.37 Mn |
| Jun 30, 2024 | 49.19 Mn |
| Mar 31, 2024 | 48.68 Mn |
| Dec 31, 2023 | 72.62 Mn |
| Sep 30, 2023 | 47.73 Mn |
| Jun 30, 2023 | 69.85 Mn |
| Mar 31, 2023 | 68.82 Mn |
| Dec 31, 2022 | 68.19 Mn |
| Sep 30, 2022 | 256,745.00 |
| Dec 31, 2021 | 126,422.00 |
API Access
Citius Oncology Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();